Tag: PEDIATRIC

Obstructive Sleep Apnea Industry News Pediatrics

Dormotech Highlights the Critical Need for Early Pediatric Sleep Apnea Diagnosis with Insights from Dr. Asher Tal

Dormotech, a leader in advancing sleep diagnostics through innovative, clinically validated solutions, emphasized the urgent need for early and accessible diagnosis of sleep disorders in children. This critical focus echoes the profound insights shared by globally respected pediatric sleep medicine expert, Dr. Asher Tal. In an in-depth interview with Dormotech, […]

Pediatrics Mental & Behavioral Health Research/Studies

Sleep To Live Well Foundation Launches With Groundbreaking Sleep Wellness Report

The Sleep To Live Well Foundation issues an urgent warning in its groundbreaking 2025 State of Sleep Wellness Report, titled “THE SILENT EPIDEMIC: How Lack of Sleep Endangers Over Half of All Americans and Threatens Everyone.” The report unveils the Foundation’s initiatives to address this insufficient sleep crisis with Sleep Wellness—a holistic approach to […]

Asian boy asthma
Pediatrics

Steep Drop in Pediatric Asthma ER Visits During Spring Lockdown

A new study published online in the Annals of the American Thoracic Society discusses a steep drop off from prior years in asthma-related emergency department (ED) visits at Boston Children’s Hospital during the spring 2020 COVID-19 surge and lockdown. In “Impact of the COVID-19 Pandemic on Pediatric Emergency Department Utilization for Asthma,” Tregony Simoneau, MD, assistant professor […]

masimo ori
Product/Vendor Updates

Masimo ORi Can Predict Need for Postoperative O2 Therapy in Peds with OSA

Masimo announced the findings of an abstract recently presented at ANESTHESIOLOGY® 2020, the Annual Meeting of the American Society of Anesthesiologists (ASA). In this independent, retrospective study, researchers investigated whether Masimo ORi™ (Oxygen Reserve Index) could predict whether children with obstructive sleep apnea syndrome (OSAS) undergoing tonsillectomy required postoperative oxygen therapy. […]

cystic fibrosis lungs
Pediatrics Sleep Pharmaceuticals

FDA Grants SPIRO-2101 CF Treatment Orphan Drug and Rare Pediatric Disease Designations 

Spirovant Sciences, a gene therapy company developing treatments and cures for genetic lung diseases including cystic fibrosis, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug and Rare Pediatric Disease Designations to its lead product candidate, SPIRO-2101, for the treatment of cystic fibrosis. SPIRO-2101, an inhaled […]

oxygen delivery
Pediatrics Respiratory

New Clinical Guideline on Home Oxygen for Children

The American Thoracic Society has developed a new clinical practice guideline for home oxygen therapy for children. The guideline appears in the Feb. 1 edition of the Society’s American Journal of Respiratory and Critical Care Medicine. “Home Oxygen Therapy for Children: An Official American Thoracic Society Clinical Practice Guideline”   makes specific recommendations […]